by ASTCT Advocacy Update
The U.S. Food and Drug Administration (FDA) has announced that Risk Evaluation and Mitigation Strategies (REMS) will no longer be required for BCMA- and CD19-directed autologous CAR T cell...
by ASTCT Advocacy Update
ASTCT Submits Recommendations to OMB to Improve Access to Stem Cell and Cellular Therapies
by ASTCT Advocacy Update
CMS Transmittal on the National Coverage Decision for MDS
by ASTCT Advocacy Update
ASTCT Weighs in on Medicare Cuts in Funding Bill
by ASTCT Advocacy Update
The ASTCT Committee on Payer Relations has updated its standardized Request for Information (RFI) forms for 2025.
by ASTCT Advocacy Update
ASTCT submitted comments and codes to CMS as part of the Interim Final OPPS Rule for Caregiver Training Services (CTS).